Do you want to read an article? Please log in or register.
Risks and benefits of clopidogrel-aspirin in minor stroke or TIA: Time course analysis of CHANCE
Stroke
Related content
Stroke
Antiplatelet Use and Ischemic Stroke Risk in Minor Stroke or Transient Ischemic Attack: A Post Hoc Analysis of the POINT Trial
Stroke
Anadani M, de Havenon A, Henninger N, Kuohn L, Mac Grory B, Furie KL, Kim AS, Easton JD, Johnston SC, Yaghi S
doi: 10.1161/STROKEAHA.121.035354
Stroke
Benefits and Risks of Dual Versus Single Antiplatelet Therapy for Secondary Stroke Prevention: A Systematic Review for the 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
Stroke
Brown DL, Levine DA, Albright K, Kapral MK, Leung LY, Reeves MJ, Sico J, Strong B, Whiteley WN, American Heart Association Stroke Council.
doi: 10.1161/STR.0000000000000377
Stroke
Carotid Stenosis and Recurrent Ischemic Stroke: A Post-Hoc Analysis of the POINT Trial
Stroke
Yaghi S, de Havenon A, Rostanski S, Kvernland A, Mac Grory B, Furie KL, Kim AS, Easton JD, Johnston SC, Henninger N
doi: 10.1161/STROKEAHA.121.034089
RECOMMENDED
Stroke
Stroke Risk Analysis, a System With a High Detection Rate of Atrial Fibrillation in Stroke and Transient Ischemic Attack
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Stroke.
Gomis M, Dávalos A, Purroy F, Cardona P, Rodríguez-Campello A, Martí-Fábregas J, Pagola J, Pardo L, Muñoz-Narbona L, Benabdelhak I, Lara-Rodríguez B, Cuadrado-Godia E, Martínez-Domeño A, Juega JM, Serena J, Alvarez-Ballano J, Paipa A, Roquer J, Abilleira S, Neeter R, van de Groep A, Molina C
doi: 10.1161/STROKEAHA.119.026354.
Stroke
Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial
Lancet Neurol.
Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Hill MD, Jonasson J, Kasner SE, Ladenvall P, Minematsu K, Molina CA, Wang Y, Wong KS, Johnston SC; SOCRATES Steering Committee and Investigators
doi: 10.1016/
Stroke
Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials
Stroke.
Kent DM, Saver JL, Ruthazer R, Furlan AJ, Reisman M, Carroll JD, Smalling RW, Jüni P, Mattle HP, Meier B, Thaler DE
doi: 10.1161/STROKEAHA.
Stroke
Cilostazol for Secondary Prevention of Stroke and Cognitive Decline: Systematic Review and Meta-Analysis
Stroke.
McHutchison C, Blair GW, Appleton JP, Chappell FM, Doubal F, Bath PM, Wardlaw JM
doi: 10.1161/STROKEAHA.120.029454.
Stroke
Anticoagulation Timing in Cardioembolic Stroke and Recurrent Event Risk
Ann Neurol.
Yaghi S, Trivedi T, Henninger N, Giles J, Liu A, Nagy M, Kaushal A, Azher I, Grory BM, Fakhri H, Espaillat KB, Asad SD, Pasupuleti H, Martin H, Tan J, Veerasamy M, Liberman AL, Esenwa C, Cheng N, Moncrieffe K, Moeini-Naghani I, Siddu M, Scher E, Leon Guerrero CR, Khan M, Nouh A, Mistry E, Keyrouz S, Furie K
doi: 10.1002/ana.25844.
Stroke
Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin
Stroke
Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Knutsson M, Ladenvall P, Molina CA, Wang Y, Johnston SC, THALES Steering Committee and Investigators.
doi: 10.1161/STROKEAHA.120.032239